Welcome to our dedicated page for Real Brokerage SEC filings (Ticker: REAX), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Real Brokerage Inc. (REAX) has upended the traditional real-estate model with its cloud platform, revenue-share economics and proprietary reZEN software. That innovation makes its SEC disclosures unusually rich: investors comb the filings for agent-count momentum, commission splits, technology spend and stock-based incentives—details buried in hundreds of pages.
This page delivers every document the instant it hits EDGAR, from the Real Brokerage annual report 10-K simplified to each Real Brokerage quarterly earnings report 10-Q filing. Stock Titan’s AI produces concise, plain-English summaries so understanding Real Brokerage SEC documents with AI feels as straightforward as reading a headline. Need to catch executive moves? Real Brokerage insider trading Form 4 transactions surface in real time, along with alerts covering Real Brokerage executive stock transactions Form 4 and Real Brokerage 8-K material events explained. You’ll also find the Real Brokerage proxy statement executive compensation and shelf registrations—all in one place.
With AI-powered highlights you can:
- Run a Real Brokerage earnings report filing analysis that tracks commission revenue trends quarter over quarter
- Monitor Real Brokerage Form 4 insider transactions real-time before market-moving announcements
- Quickly review board proposals inside the Real Brokerage proxy statement executive compensation section
Whether you’re modeling cash flows or assessing dilution risk, this library of Real Brokerage SEC filings explained simply turns hours of document hunting into minutes of insight.
Real Brokerage Inc. (REAX) filed a Form 144 reporting a proposed sale of 7,591 common shares with an aggregate market value of $34,159.50, to be sold on or about 08/15/2025 on NASDAQ. The shares were acquired the same day via a stock option exercise and paid for in cash. The filing lists the total number of outstanding shares as 208,121,000. The notice also includes an extensive list of prior open-market sales over the past three months by Tamir Poleg, consisting of multiple transactions of common stock on dates from 05/16/2025 through 08/13/2025, including several large blocks (tens of thousands of shares) with individual gross proceeds in the hundreds of thousands of dollars.
Real Brokerage Inc. (REAX) Form 144 notice reports proposed and recent sales of common stock by an insider. The notice shows a planned sale of 6,692 restricted shares (acquired 03/13/2025 from the issuer) with an aggregate market value of $30,114, to be sold approximately on 08/15/2025 on NASDAQ through Morgan Stanley Smith Barney LLC. The filing also discloses two recent sales by Pritesh Damani on 08/14/2025 totaling 20,986 shares for gross proceeds of $94,529.34 (split as 16,027 shares for $72,192.02 and 4,959 shares for $22,337.32). The filer certifies no undisclosed material adverse information.
Real Brokerage Inc (REAX) filed a Form 144 reporting a proposed sale of 20,986 common shares through Morgan Stanley Smith Barney LLC with an aggregate market value of $94,529.34. The filing shows approximately 208,121,000 shares outstanding and lists an approximate sale date of 08/14/2025 on NASDAQ. The shares to be sold were acquired as restricted stock from the issuer on 03/13/2025 (4,959 shares) and 06/13/2025 (16,027 shares). No securities were reported sold by the seller in the past three months. The filer affirms no undisclosed material adverse information in the issuer's operations.
Insight Partners and affiliated entities disclosed joint beneficial ownership of common shares of Real Brokerage Inc (REAX), totaling 28,698,997 shares, representing 13.8% of the outstanding class based on ~208,121,000 shares as of June 30, 2025. The filing lists multiple related reporting persons across Cayman, Delaware and Luxembourg entities and describes the ownership split between sole and shared voting/dispositive power (all reported as 0 sole and 28,698,997 shared).
The report is a Schedule 13G/A amendment signed on 08/14/2025 and includes a joint filing agreement (Exhibit 99.1). The cover pages show individual holdings of the affiliated funds and entities that aggregate to the totals reported.
Real Brokerage Inc. (REAX) Form 144 reports a proposed sale of 73,334 common shares through Oppenheimer & Co., with an aggregate market value of $316,069.54. The filing lists 202,499,045 shares outstanding, so the proposed block represents a very small fraction of the total equity. The shares were originally acquired in a private placement on 06/30/2014 when the filer received 2,520,750 shares. The notice also discloses recent sales by the same person: 166,668 shares sold for $751,822.68 on 06/27/2025 and 2,400 shares sold for $10,851.12 on 08/07/2025. The form states the seller represents no undisclosed material adverse information about the issuer.
Real Brokerage Inc. (REAX) filed a Form 144 reporting a proposed sale of 50,000 common shares through Morgan Stanley Smith Barney LLC Executive Financial Services on 08/13/2025. The filing lists an aggregate market value of $223,650 and shows 208,121,000 shares outstanding for the issuer.
The Form states the shares were acquired on 08/13/2025 by stock option exercise from the issuer and payment was in cash. The filing also documents numerous sales by Tamir Poleg during May–August 2025 (examples include 100,000 shares on 06/03/2025 for $431,500 and 73,063 shares on 08/11/2025 for $301,311.81). The filer certifies no undisclosed material adverse information.
Real Brokerage Inc (REAX) filed a Form 144 disclosing a proposed sale of 12,000 common shares through Morgan Stanley Smith Barney LLC on the NASDAQ with an aggregate market value of $51,624 and an approximate sale date of 08/12/2025. The shares were acquired as restricted stock from the issuer on 03/17/2024. The filing shows 208,121,000 shares outstanding for the issuer, and notes prior sales by VIKKI BARTHOLOMAE on 05/20/2025 of 2,751 and 7,249 shares for gross proceeds of $11,968.78 and $31,538.22 respectively. The filer attests there is no undisclosed material adverse information.
Real Brokerage Inc. (REAX) filed a Form 144 reporting a proposed sale of 212,037 common shares through Morgan Stanley Smith Barney, with an aggregate market value of $906,127.88 and an approximate sale date of 08/12/2025. The shares were acquired on 08/12/2025 by stock option exercise and payment was made in cash. The filing also lists numerous prior sales by Tamir Poleg during May through August 2025, with individual transactions ranging from 93 to 100,000 shares and showing gross proceeds for each trade. The filer certifies no undisclosed material adverse information.
Real Brokerage (REAX) submitted a Form 144 notice reporting a proposed Rule 144 sale of 200,000 common shares through J.P. Morgan Securities LLC. The filing lists an aggregate market value of $788,000 and shares outstanding of 202,499,045, with an approximate sale date of 08/11/2025.
The securities were acquired on 06/05/2020 in a private investment from the issuer, totaling 200,000 shares paid in cash. The filer reports no securities sold in the past three months and makes the standard representation that they are not aware of any undisclosed material adverse information about the issuer.
Real Brokerage, Inc. (REAX) submitted a Form 144 reporting a proposed sale of 87,963 common shares to be executed through Morgan Stanley Smith Barney LLC on NASDAQ on 08/11/2025 with an aggregate market value of $363,285.38. The form shows the securities were acquired on 08/11/2025 through a stock option exercise and the payment method listed is cash. The company’s total shares outstanding are listed as 208,121,000, so the planned sale represents a very small fraction of outstanding stock.
The filing also lists numerous sales by Tamir Poleg during the past three months, including a 100,000-share sale on 06/03/2025 for $431,500.00. The filer affirms they are not aware of any undisclosed material adverse information regarding the issuer.